Knockout of Mitochondrial Thioredoxin Reductase Stabilizes Prolyl Hydroxylase 2 and Inhibits Tumor Growth and Tumor-Derived Angiogenesis
Juliane Hellfritsch(Institut für Chirurgische Forschung), Heike Beck(Friedrich-Alexander-Universität Erlangen-Nürnberg), Theres Fey(Institut für Chirurgische Forschung), Markus Wortmann(Heidelberg University), Marcus Conrad(Helmholtz Zentrum München), Arne Östman(Karolinska Institutet), Iréne Esposito(Heinrich Heine University Düsseldorf), José Pedro Friedmann Angeli(University of Würzburg), Ulrich Pohl(Centre of Experimental Medicine of the Slovak Academy of Sciences), Markus Dagnell(Karolinska Institutet), Jeroen Frijhoff(Lund University), Kristin Pogoda(University of Augsburg), Irina Ingold(TUM Klinikum), Peter Kuhlencordt(LMU Klinikum), P. Kölle(LMU Klinikum), Julian Kirsch(Institut für Chirurgische Forschung), Manuela Schneider(Institut für Chirurgische Forschung), Tamara Fluege(Center for Environmental Health)
Cited by 54
Related Papers
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
|Cell Death and Differentiation|2018|6.6k
FSP1 is a glutathione-independent ferroptosis suppressor
|Nature|2019|3.2k
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
|Nature Medicine|2001|1.7k
Reactive Oxygen Species
|Arteriosclerosis Thrombosis and Vascular Biology|2004|1k
Clinical Relevance of Biomarkers of Oxidative Stress
|Antioxidants and Redox Signaling|2015|906